Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23929378 | 1.00 | CNR2 (0.30) | CNR2 | |
| SCHEMBL23929383 | 0.84 | — | — | |
| SCHEMBL23929382 | 0.84 | — | — | |
| SCHEMBL23929388 | 0.82 | — | — | |
| SCHEMBL23929390 | 0.82 | — | — | |
| SCHEMBL23929371 | 0.78 | — | — | |
| SCHEMBL3874313 | 0.78 | USP2 (0.35) | CNR2 | |
| SCHEMBL3882705 | 0.78 | USP2 (0.35) | CNR2 | |
| SCHEMBL232038 | 0.78 | USP2 (0.35) | CNR2 | |
| SCHEMBL3874314 | 0.78 | USP2 (0.35) | CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12492356-B2 | Oxa-sandalwood-type fragrance compounds | SYMRISE AG (DE) | 2025-12-09 | — | — | US | disclosed |
| EP-4139270-B1 | OXA-SANDALWOOD-TYPE FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2025-03-05 | — | — | EP | disclosed |
| US-20230126581-A1 | Oxa-Sandalwood-Type Fragrance Compounds | SYMRISE AG (DE) | 2023-04-27 | — | — | US | disclosed |
| US-20230126581-A1 | Oxa-Sandalwood-Type Fragrance Compounds | SYMRISE AG (DE) | 2023-04-27 | — | — | US | disclosed |
| US-20230126581-A1 | Oxa-Sandalwood-Type Fragrance Compounds | SYMRISE AG (DE) | 2023-04-27 | — | — | US | disclosed |
| EP-4139270-A1 | OXA-SANDALWOOD-TYPE FRAGRANCE COMPOUNDS | Symrise AG (DE) | 2023-03-01 | — | — | EP | disclosed |
| CN-115515920-A | Oxasantalene type fragrance compounds | 西姆莱斯股份公司 | 2022-12-23 | — | — | CN | disclosed |
| WO-2021213627-A1 | OXA-SANDALWOOD-TYPE FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2021-10-28 | — | — | WO | disclosed |
| WO-2021213627-A1 | OXA-SANDALWOOD-TYPE FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2021-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12492356-B2 | Oxa-sandalwood-type fragrance compounds | FDFT1, FAAH2, ALDH1A1 | CNR2 299/4885 |
| US-20230126581-A1 | Oxa-Sandalwood-Type Fragrance Compounds | FDFT1, FAAH2, ALDH1A1 | CNR2 299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.